KATELON SMITH: Open Payments
NPI 1033673405 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,943 in 95 payments from 25 companies in 2025. Trend: 2023 $1,814 · 2024 $1,624 · 2025 $1,943
Food & beverage: $1,943
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $411 |
| Amgen Inc. | 10 | $204 |
| Alnylam Pharmaceuticals Inc. | 2 | $147 |
| Novo Nordisk Inc | 6 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| PFIZER INC. | 5 | $93 |
| Abbott Laboratories | 5 | $92 |
| Corcept Therapeutics | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
Products named: VRAYLAR, AMVUTTRA, UZEDY, REXULTI, FREESTYLE LIBRE 3, Wegovy, Korlym, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
